{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:50:23Z","timestamp":1791859823874,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01DP06491"],"award-info":[{"award-number":["U01DP06491"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["UL1 TR002377"],"award-info":[{"award-number":["UL1 TR002377"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clim.2024.109906","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T22:59:21Z","timestamp":1705618761000},"page":"109906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review"],"prefix":"10.1016","volume":"260","author":[{"given":"Jos\u00e9 A.","family":"Meade-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Figueroa-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Langenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gonz\u00e1lez-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Moynagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u00ed","family":"Duarte-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.109906_bb0005","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and Management of the Antiphospholipid Syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109906_bb0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.109906_bb0015","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.clim.2024.109906_bb0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrrheum.2017.124","article-title":"Diagnosing antiphospholipid syndrome: \u2018extra-criteria\u2019 manifestations and technical advances","volume":"13","author":"Sciascia","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.109906_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ejendo\/lvad036","article-title":"Rare benign adrenal lesions","volume":"188","author":"Dogra","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clim.2024.109906_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0025-6196(11)63123-6","article-title":"Adrenal hemorrhage: a 25-year experience at the Mayo Clinic","volume":"76","author":"Vella","year":"2001","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.clim.2024.109906_bb0035","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.clim.2024.109906_bb0040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.109906_bb0045","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s11606-020-05783-5","article-title":"A narrative review and proposed framework for using health system data with systematic reviews to support decision-making","volume":"35","author":"Lin","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.clim.2024.109906_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.109906_bb0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic Antiphospholipid Syndrome Registry Project, Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2024.109906_bb0060","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109906_bb0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0025-6196(12)65129-5","article-title":"Adrenal insufficiency from bilateral adrenal hemorrhage","volume":"65","author":"Siu","year":"1990","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clim.2024.109906_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid.-Based Med."},{"key":"10.1016\/j.clim.2024.109906_bb0075","series-title":"Conference: 97th Annual Meeting and Expo of the Endocrine Society","article-title":"Bilateral adrenal hemorrhage-an unusual manifestation of antiphospholipid syndrome, Endocrine Reviews","volume":"36","author":"Ahmad","year":"2015"},{"key":"10.1016\/j.clim.2024.109906_bb0080","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1136\/bcr-2020-234947","article-title":"Bilateral adrenal haemorrhage secondary to rivaroxaban in a patient with antiphospholipid syndrome","volume":"13","author":"Arosemena","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2024.109906_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1752-1947-9-18","article-title":"Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case report","volume":"9","author":"Jaafar","year":"2015","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.clim.2024.109906_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-110-3-227","article-title":"Bilateral massive adrenal hemorrhage: early recognition and treatment","volume":"110","author":"Rao","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2024.109906_bb0095","series-title":"Laparoscopic Surgery","first-page":"91","article-title":"Laparoscopic Left Adrenalectomy with Submesocolic and Retropancreatic Approach","author":"Balla","year":"2017"},{"key":"10.1016\/j.clim.2024.109906_bb0100","first-page":"113","article-title":"Laparoscopic Adrenalectomy. In: Laparoscopy -","author":"Parnaby","year":"2011","journal-title":"An Interdisciplinary Approach"},{"key":"10.1016\/j.clim.2024.109906_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","article-title":"Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients","volume":"82","author":"Espinosa","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2024.109906_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000107","article-title":"Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE","volume":"3","author":"Domingues","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.clim.2024.109906_bb0115","doi-asserted-by":"crossref","first-page":"102395","DOI":"10.1016\/j.autrev.2019.102395","article-title":"Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"18","author":"Chock","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.109906_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1985.tb02988.x","article-title":"Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody","volume":"59","author":"Harris","year":"1985","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2024.109906_bb0125","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/rheumatology\/keac466","article-title":"Antiphospholipid antibodies in patients with calcific aortic valve stenosis","volume":"62","author":"Plunde","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2024.109906_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2024.109906_bb0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/joim.13409","article-title":"Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries","volume":"291","author":"Svenungsson","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clim.2024.109906_bb0140","doi-asserted-by":"crossref","first-page":"103158","DOI":"10.1016\/j.autrev.2022.103158","article-title":"Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Domingues","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.109906_bb0145","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1177\/09612033221126852","article-title":"Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"31","author":"Loiseau","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2024.109906_bb0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.15537\/smj.2018.8.22437","article-title":"Bilateral adrenal hemorrhage in antiphospholipid syndrome. Anticoagulation for the treatment of hemorrhage","volume":"39","author":"Aldaajani","year":"2018","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.clim.2024.109906_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjab440","article-title":"The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report","volume":"2021","author":"Aneke","year":"2021","journal-title":"J. Surg. Case Rep."},{"key":"10.1016\/j.clim.2024.109906_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"European Working Party on Systemic Lupus, Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2024.109906_bb0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203309106833","article-title":"The CAPS registry: morbidity and mortality of the catastrophic antiphospholipid syndrome","volume":"18","author":"Bucciarelli","year":"2009","journal-title":"Lupus"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:10:22Z","timestamp":1761495022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"alternative-id":["S1521661624000172"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.109906","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.109906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109906"}}